A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.
about
The Adenosinergic System in Diabetic RetinopathyAdenosine receptors and caffeine in retinopathy of prematurity.ERK1/2/COX-2/PGE2 signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes.The role of microglia in diabetic retinopathyEffect of diabetes/hyperglycemia on the rat retinal adenosinergic systemAdenosine A1 Receptors Selectively Modulate Oxygen-Induced Retinopathy at the Hyperoxic and Hypoxic Phases by Distinct Cellular Mechanisms.Regulation of Adenosine Deaminase on Induced Mouse Experimental Autoimmune Uveitis.Role of adenosine in diabetic retinopathy.The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge.Purinergic receptors in ocular inflammation.The microRNA-7-mediated reduction in EPAC-1 contributes to vascular endothelial permeability and eNOS uncoupling in murine experimental retinopathy.A cross talk between class A scavenger receptor and receptor for advanced glycation end-products contributes to diabetic retinopathy.Neural inflammation and the microglial response in diabetic retinopathy.Purinergic Signalling: Therapeutic Developments.Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure.Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage.
P2860
Q26748944-06504114-11F2-4E64-A3C5-898D0E890E24Q33860622-85EE8FBC-D977-44CC-9A3C-50D0428A9FC7Q33990723-8F51F420-7861-4C88-B820-5273586AEC36Q34199146-17542F35-6E28-46FD-A004-251474B32983Q34807525-544D1857-E91D-437E-9739-C17CDB066C66Q36424969-B4128440-939D-4A0C-8C58-B29536B22E45Q36655815-3D5963C5-9ED4-4094-B04F-EBB93F264440Q38073250-B22A3136-22F0-468D-B3ED-BC7C2670B823Q38101684-45BEF050-EF34-43DD-8EE3-F57FCE7A7148Q38240836-00B50CF7-B932-4F55-8FA9-72A60061F14AQ38869656-458CD932-8DDE-474A-B052-566EE7BA42C1Q38944230-03155534-EF9D-42A9-B105-3FE46261498BQ42144753-30A959B0-0FDE-4A3F-93DF-071E9AED2E6DQ42367885-19B8BBE4-D529-41D0-B6F7-AF0037E6381CQ42496976-F57A3F0F-DB61-4B99-8FBF-5A46C1CC3494Q47387315-87388E5C-3172-42A0-B9A7-015BAE12ECFD
P2860
A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.
@ast
A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.
@en
type
label
A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.
@ast
A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.
@en
prefLabel
A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.
@ast
A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.
@en
P2093
P2860
P1476
A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.
@en
P2093
Gregory I Liou
Mamdouh M El-Shishtawy
Wenbo Zhang
P2860
P304
P356
10.1016/J.AJPATH.2011.01.018
P407
P577
2011-05-01T00:00:00Z